nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.385	1	CbGbCtD
Ketorolac—Tolmetin—CXCL8—chronic obstructive pulmonary disease	0.0042	0.343	CrCbGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00405	0.0948	CbGpPWpGaD
Ketorolac—Tolmetin—MPO—chronic obstructive pulmonary disease	0.00326	0.267	CrCbGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00322	0.0753	CbGpPWpGaD
Ketorolac—PTGS2—leg—chronic obstructive pulmonary disease	0.00254	0.311	CbGeAlD
Ketorolac—Mebendazole—CYP1A1—chronic obstructive pulmonary disease	0.00221	0.18	CrCbGaD
Ketorolac—Ketoprofen—CXCL8—chronic obstructive pulmonary disease	0.00205	0.167	CrCbGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00151	0.0354	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00141	0.033	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.0012	0.0281	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00118	0.0277	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.00109	0.0255	CbGpPWpGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000989	0.0231	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000984	0.023	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00094	0.022	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000856	0.02	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000848	0.0198	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000785	0.0184	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000781	0.0183	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.00077	0.018	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000767	0.0179	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000719	0.0168	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000673	0.0157	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000661	0.0155	CbGpPWpGaD
Ketorolac—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000659	0.0808	CbGeAlD
Ketorolac—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.00063	0.0773	CbGeAlD
Ketorolac—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000616	0.0144	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000611	0.0143	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000594	0.0139	CbGpPWpGaD
Ketorolac—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.00058	0.0711	CbGeAlD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.00057	0.0133	CbGpPWpGaD
Ketorolac—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000554	0.068	CbGeAlD
Ketorolac—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000544	0.0127	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000536	0.0125	CbGpPWpGaD
Ketorolac—Ketoprofen—ALB—chronic obstructive pulmonary disease	0.000532	0.0434	CrCbGaD
Ketorolac—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000531	0.0651	CbGeAlD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000526	0.0123	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000524	0.0123	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000523	0.0122	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000521	0.0122	CbGpPWpGaD
Ketorolac—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000518	0.0636	CbGeAlD
Ketorolac—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000507	0.0622	CbGeAlD
Ketorolac—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000507	0.000918	CcSEcCtD
Ketorolac—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.000914	CcSEcCtD
Ketorolac—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000503	0.000912	CcSEcCtD
Ketorolac—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000503	0.000911	CcSEcCtD
Ketorolac—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000502	0.000909	CcSEcCtD
Ketorolac—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000502	0.000909	CcSEcCtD
Ketorolac—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000501	0.000908	CcSEcCtD
Ketorolac—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000498	0.000902	CcSEcCtD
Ketorolac—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000497	0.0116	CbGpPWpGaD
Ketorolac—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000496	0.000899	CcSEcCtD
Ketorolac—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.000895	CcSEcCtD
Ketorolac—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.000895	CcSEcCtD
Ketorolac—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00089	CcSEcCtD
Ketorolac—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000489	0.000886	CcSEcCtD
Ketorolac—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.000886	CcSEcCtD
Ketorolac—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000489	0.0114	CbGpPWpGaD
Ketorolac—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000489	0.000885	CcSEcCtD
Ketorolac—PTGS1—trachea—chronic obstructive pulmonary disease	0.000487	0.0597	CbGeAlD
Ketorolac—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000487	0.000882	CcSEcCtD
Ketorolac—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.000881	CcSEcCtD
Ketorolac—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000486	0.00088	CcSEcCtD
Ketorolac—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.000878	CcSEcCtD
Ketorolac—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.000874	CcSEcCtD
Ketorolac—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00087	CcSEcCtD
Ketorolac—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000478	0.000866	CcSEcCtD
Ketorolac—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.000866	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000477	0.000864	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.000864	CcSEcCtD
Ketorolac—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000473	0.000858	CcSEcCtD
Ketorolac—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.000858	CcSEcCtD
Ketorolac—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.000854	CcSEcCtD
Ketorolac—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.000853	CcSEcCtD
Ketorolac—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000468	0.000849	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000467	0.000846	CcSEcCtD
Ketorolac—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000467	0.000845	CcSEcCtD
Ketorolac—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000467	0.000845	CcSEcCtD
Ketorolac—PTGS2—trachea—chronic obstructive pulmonary disease	0.000465	0.0571	CbGeAlD
Ketorolac—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000465	0.000843	CcSEcCtD
Ketorolac—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000465	0.000843	CcSEcCtD
Ketorolac—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000464	0.00084	CcSEcCtD
Ketorolac—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000462	0.000837	CcSEcCtD
Ketorolac—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.000837	CcSEcCtD
Ketorolac—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.000835	CcSEcCtD
Ketorolac—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000461	0.000835	CcSEcCtD
Ketorolac—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00046	0.000834	CcSEcCtD
Ketorolac—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000459	0.000831	CcSEcCtD
Ketorolac—Injury—Prednisone—chronic obstructive pulmonary disease	0.000456	0.000826	CcSEcCtD
Ketorolac—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000456	0.000826	CcSEcCtD
Ketorolac—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000455	0.000824	CcSEcCtD
Ketorolac—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000454	0.000822	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000452	0.000819	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.000819	CcSEcCtD
Ketorolac—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000451	0.000818	CcSEcCtD
Ketorolac—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000451	0.000818	CcSEcCtD
Ketorolac—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.000818	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.000816	CcSEcCtD
Ketorolac—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.000811	CcSEcCtD
Ketorolac—Pain—Formoterol—chronic obstructive pulmonary disease	0.000448	0.000811	CcSEcCtD
Ketorolac—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000448	0.000811	CcSEcCtD
Ketorolac—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.000811	CcSEcCtD
Ketorolac—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00081	CcSEcCtD
Ketorolac—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000446	0.000808	CcSEcCtD
Ketorolac—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.000804	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000443	0.000802	CcSEcCtD
Ketorolac—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000442	0.000801	CcSEcCtD
Ketorolac—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.000798	CcSEcCtD
Ketorolac—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000439	0.000796	CcSEcCtD
Ketorolac—Pain—Montelukast—chronic obstructive pulmonary disease	0.000438	0.000794	CcSEcCtD
Ketorolac—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000438	0.000794	CcSEcCtD
Ketorolac—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.000792	CcSEcCtD
Ketorolac—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.000789	CcSEcCtD
Ketorolac—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.000788	CcSEcCtD
Ketorolac—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000435	0.000788	CcSEcCtD
Ketorolac—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.000786	CcSEcCtD
Ketorolac—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000433	0.000785	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000433	0.0101	CbGpPWpGaD
Ketorolac—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000432	0.000783	CcSEcCtD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000431	0.0101	CbGpPWpGaD
Ketorolac—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.000781	CcSEcCtD
Ketorolac—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000431	0.000781	CcSEcCtD
Ketorolac—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000431	0.000781	CcSEcCtD
Ketorolac—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.000778	CcSEcCtD
Ketorolac—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000429	0.000778	CcSEcCtD
Ketorolac—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000429	0.000777	CcSEcCtD
Ketorolac—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.000775	CcSEcCtD
Ketorolac—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000428	0.000775	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.000773	CcSEcCtD
Ketorolac—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.000772	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000426	0.00996	CbGpPWpGaD
Ketorolac—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.000766	CcSEcCtD
Ketorolac—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.000766	CcSEcCtD
Ketorolac—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00076	CcSEcCtD
Ketorolac—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000759	CcSEcCtD
Ketorolac—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000759	CcSEcCtD
Ketorolac—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.000753	CcSEcCtD
Ketorolac—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000416	0.000753	CcSEcCtD
Ketorolac—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00075	CcSEcCtD
Ketorolac—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00075	CcSEcCtD
Ketorolac—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00075	CcSEcCtD
Ketorolac—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00075	CcSEcCtD
Ketorolac—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000412	0.000747	CcSEcCtD
Ketorolac—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000409	0.000742	CcSEcCtD
Ketorolac—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.000741	CcSEcCtD
Ketorolac—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00074	CcSEcCtD
Ketorolac—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000408	0.00074	CcSEcCtD
Ketorolac—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000407	0.000738	CcSEcCtD
Ketorolac—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.000738	CcSEcCtD
Ketorolac—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.000736	CcSEcCtD
Ketorolac—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000406	0.000736	CcSEcCtD
Ketorolac—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000405	0.000734	CcSEcCtD
Ketorolac—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000405	0.000734	CcSEcCtD
Ketorolac—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000405	0.000733	CcSEcCtD
Ketorolac—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.000732	CcSEcCtD
Ketorolac—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000401	0.000727	CcSEcCtD
Ketorolac—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000399	0.000723	CcSEcCtD
Ketorolac—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.000711	CcSEcCtD
Ketorolac—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.000708	CcSEcCtD
Ketorolac—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.000708	CcSEcCtD
Ketorolac—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000386	0.000699	CcSEcCtD
Ketorolac—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.000699	CcSEcCtD
Ketorolac—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.000698	CcSEcCtD
Ketorolac—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.000697	CcSEcCtD
Ketorolac—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000381	0.000691	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00038	0.00888	CbGpPWpGaD
Ketorolac—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000378	0.000684	CcSEcCtD
Ketorolac—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00068	CcSEcCtD
Ketorolac—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00068	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000375	0.00878	CbGpPWpGaD
Ketorolac—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.000671	CcSEcCtD
Ketorolac—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00037	0.000671	CcSEcCtD
Ketorolac—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000368	0.000666	CcSEcCtD
Ketorolac—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000365	0.000661	CcSEcCtD
Ketorolac—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00066	CcSEcCtD
Ketorolac—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000363	0.000657	CcSEcCtD
Ketorolac—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000358	0.000649	CcSEcCtD
Ketorolac—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.000649	CcSEcCtD
Ketorolac—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000356	0.000646	CcSEcCtD
Ketorolac—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000355	0.000643	CcSEcCtD
Ketorolac—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.000642	CcSEcCtD
Ketorolac—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000353	0.000639	CcSEcCtD
Ketorolac—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000351	0.000636	CcSEcCtD
Ketorolac—PTGS1—lung—chronic obstructive pulmonary disease	0.00035	0.0429	CbGeAlD
Ketorolac—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.000634	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000347	0.00813	CbGpPWpGaD
Ketorolac—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.000629	CcSEcCtD
Ketorolac—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000346	0.000627	CcSEcCtD
Ketorolac—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.000627	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000343	0.00804	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000341	0.00797	CbGpPWpGaD
Ketorolac—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000339	0.000614	CcSEcCtD
Ketorolac—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.000613	CcSEcCtD
Ketorolac—PTGS2—lung—chronic obstructive pulmonary disease	0.000334	0.041	CbGeAlD
Ketorolac—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.000603	CcSEcCtD
Ketorolac—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000333	0.000603	CcSEcCtD
Ketorolac—Rash—Formoterol—chronic obstructive pulmonary disease	0.00033	0.000598	CcSEcCtD
Ketorolac—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.000598	CcSEcCtD
Ketorolac—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.000597	CcSEcCtD
Ketorolac—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00033	0.000597	CcSEcCtD
Ketorolac—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00033	0.000597	CcSEcCtD
Ketorolac—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.000594	CcSEcCtD
Ketorolac—Headache—Formoterol—chronic obstructive pulmonary disease	0.000328	0.000594	CcSEcCtD
Ketorolac—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.000593	CcSEcCtD
Ketorolac—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.000592	CcSEcCtD
Ketorolac—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000592	CcSEcCtD
Ketorolac—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000326	0.000591	CcSEcCtD
Ketorolac—Rash—Montelukast—chronic obstructive pulmonary disease	0.000323	0.000586	CcSEcCtD
Ketorolac—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000323	0.000585	CcSEcCtD
Ketorolac—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.000584	CcSEcCtD
Ketorolac—Headache—Montelukast—chronic obstructive pulmonary disease	0.000321	0.000582	CcSEcCtD
Ketorolac—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000577	CcSEcCtD
Ketorolac—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.000575	CcSEcCtD
Ketorolac—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000574	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000315	0.00738	CbGpPWpGaD
Ketorolac—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.000569	CcSEcCtD
Ketorolac—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000313	0.000567	CcSEcCtD
Ketorolac—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.000565	CcSEcCtD
Ketorolac—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.000565	CcSEcCtD
Ketorolac—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.000564	CcSEcCtD
Ketorolac—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.000564	CcSEcCtD
Ketorolac—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000311	0.000563	CcSEcCtD
Ketorolac—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.000563	CcSEcCtD
Ketorolac—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.000561	CcSEcCtD
Ketorolac—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000305	0.000553	CcSEcCtD
Ketorolac—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000304	0.000552	CcSEcCtD
Ketorolac—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000301	0.000545	CcSEcCtD
Ketorolac—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.000543	CcSEcCtD
Ketorolac—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000535	CcSEcCtD
Ketorolac—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.000532	CcSEcCtD
Ketorolac—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.000529	CcSEcCtD
Ketorolac—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000528	CcSEcCtD
Ketorolac—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00029	0.000525	CcSEcCtD
Ketorolac—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000523	CcSEcCtD
Ketorolac—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000516	CcSEcCtD
Ketorolac—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.000514	CcSEcCtD
Ketorolac—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.000514	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000282	0.0066	CbGpPWpGaD
Ketorolac—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.000505	CcSEcCtD
Ketorolac—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.000501	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000276	0.00646	CbGpPWpGaD
Ketorolac—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.000496	CcSEcCtD
Ketorolac—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000491	CcSEcCtD
Ketorolac—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000488	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000267	0.00624	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000267	0.00624	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000266	0.00623	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000263	0.00616	CbGpPWpGaD
Ketorolac—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000263	0.000477	CcSEcCtD
Ketorolac—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000474	CcSEcCtD
Ketorolac—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000469	CcSEcCtD
Ketorolac—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.000465	CcSEcCtD
Ketorolac—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000464	CcSEcCtD
Ketorolac—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.000461	CcSEcCtD
Ketorolac—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00046	CcSEcCtD
Ketorolac—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000457	CcSEcCtD
Ketorolac—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000457	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000245	0.00573	CbGpPWpGaD
Ketorolac—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000439	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000242	0.00566	CbGpPWpGaD
Ketorolac—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000431	CcSEcCtD
Ketorolac—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000424	CcSEcCtD
Ketorolac—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.000423	CcSEcCtD
Ketorolac—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000423	CcSEcCtD
Ketorolac—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00042	CcSEcCtD
Ketorolac—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000418	CcSEcCtD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.00023	0.00539	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00536	CbGpPWpGaD
Ketorolac—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000412	CcSEcCtD
Ketorolac—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000411	CcSEcCtD
Ketorolac—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00041	CcSEcCtD
Ketorolac—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000408	CcSEcCtD
Ketorolac—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000402	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.00022	0.00516	CbGpPWpGaD
Ketorolac—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000396	CcSEcCtD
Ketorolac—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000395	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000217	0.00507	CbGpPWpGaD
Ketorolac—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000389	CcSEcCtD
Ketorolac—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000389	CcSEcCtD
Ketorolac—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000388	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000213	0.005	CbGpPWpGaD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000387	CcSEcCtD
Ketorolac—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000385	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000212	0.00496	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000212	0.00496	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000211	0.00495	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.00021	0.00491	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000209	0.00489	CbGpPWpGaD
Ketorolac—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000378	CcSEcCtD
Ketorolac—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000373	CcSEcCtD
Ketorolac—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000373	CcSEcCtD
Ketorolac—Infection—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000371	CcSEcCtD
Ketorolac—Shock—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000367	CcSEcCtD
Ketorolac—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000366	CcSEcCtD
Ketorolac—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000364	CcSEcCtD
Ketorolac—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000363	CcSEcCtD
Ketorolac—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000361	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000199	0.00466	CbGpPWpGaD
Ketorolac—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000356	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000196	0.00459	CbGpPWpGaD
Ketorolac—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00034	CcSEcCtD
Ketorolac—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00034	CcSEcCtD
Ketorolac—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000338	CcSEcCtD
Ketorolac—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000335	CcSEcCtD
Ketorolac—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000184	0.00432	CbGpPWpGaD
Ketorolac—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000329	CcSEcCtD
Ketorolac—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000324	CcSEcCtD
Ketorolac—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000324	CcSEcCtD
Ketorolac—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000324	CcSEcCtD
Ketorolac—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000322	CcSEcCtD
Ketorolac—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.000322	CcSEcCtD
Ketorolac—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000319	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000172	0.00403	CbGpPWpGaD
Ketorolac—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000308	CcSEcCtD
Ketorolac—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000305	CcSEcCtD
Ketorolac—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000305	CcSEcCtD
Ketorolac—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000296	CcSEcCtD
Ketorolac—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000295	CcSEcCtD
Ketorolac—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000295	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000157	0.00368	CbGpPWpGaD
Ketorolac—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000275	CcSEcCtD
Ketorolac—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000268	CcSEcCtD
Ketorolac—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000146	0.00343	CbGpPWpGaD
Ketorolac—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000264	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000142	0.00332	CbGpPWpGaD
Ketorolac—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000255	CcSEcCtD
Ketorolac—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000247	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000136	0.00318	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000131	0.00308	CbGpPWpGaD
Ketorolac—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000237	CcSEcCtD
Ketorolac—Rash—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000235	CcSEcCtD
Ketorolac—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000235	CcSEcCtD
Ketorolac—Headache—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000234	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000128	0.003	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000127	0.00297	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000125	0.00292	CbGpPWpGaD
Ketorolac—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000222	CcSEcCtD
Ketorolac—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000122	0.00286	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00283	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	0.000119	0.00278	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00011	0.00259	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000106	0.00247	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000104	0.00244	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000104	0.00243	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000101	0.00236	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	9.88e-05	0.00231	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.7e-05	0.00227	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.62e-05	0.00225	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	9.43e-05	0.00221	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.8e-05	0.00206	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.77e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	8.71e-05	0.00204	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	7.97e-05	0.00186	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.84e-05	0.00183	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.19e-05	0.00168	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.05e-05	0.00165	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.99e-05	0.00164	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.72e-05	0.00157	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.49e-05	0.00152	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.42e-05	0.0015	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.98e-05	0.0014	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.92e-05	0.00139	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.86e-05	0.00137	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.39e-05	0.00126	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	5.17e-05	0.00121	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.15e-05	0.00121	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.09e-05	0.00119	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KL—chronic obstructive pulmonary disease	4.81e-05	0.00113	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.75e-05	0.00111	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.65e-05	0.00109	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.5e-05	0.00105	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.44e-05	0.00104	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.28e-05	0.001	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.13e-05	0.000968	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.92e-05	0.000917	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	3.6e-05	0.000843	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.57e-05	0.000836	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.52e-05	0.000824	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.28e-05	0.000768	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.11e-05	0.000728	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	3.01e-05	0.000703	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	2.66e-05	0.000624	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.55e-05	0.000596	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	2.53e-05	0.000592	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	2.42e-05	0.000565	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	2.12e-05	0.000495	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.02e-05	0.000473	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.6e-05	0.000374	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.57e-05	0.000367	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	1.2e-05	0.000282	CbGpPWpGaD
